Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone

References

• Tough SC, Hessel PA, Green FH, . Factors that influence emergency department visits for asthma. Can Respir J 1999; 6:429–35
   PubMedGoogle Scholar
• Dales RE, Schweitzer I, Kerr P, . Risk factors for recurrent emergency department visits for asthma. Thorax 1995; 50:520–4
   PubMed Web of Science ®Google Scholar
• Crane J, Pearce N, Burgess C, . Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol 1992; 21:737–44
   PubMed Web of Science ®Google Scholar
• Schatz M, Mosen D, Apter AJ, . Relationship of validated psychometric tools to subsequent medical utilization for asthma. J Allergy Clin Immunol 2005; 115:564–70
   PubMed Web of Science ®Google Scholar
• El-Ekiabyn A, Brianas L, Skowronski ME, . Impact of race on the severity of acute episodes of asthma and adrenergic responsiveness. Am J Respir Crit Care Med 2006; 174:508–13
   PubMed Web of Science ®Google Scholar
• Emerman CL, Woodruff PG, Cydulka RK, . Prospective multicenter study of relapse following treatment for acute asthma among adults presenting to the emergency department. MARC investigators. Multicenter Asthma Research Collaboration. Chest 1999; 115:919–27
   PubMed Web of Science ®Google Scholar
• Ford JG, Meyer IH, Sernfels P, . Patterns and predictors of asthma-related emergency department use in Harlem. Chest 2001; 120:1129–35
   PubMed Web of Science ®Google Scholar
• Eisner MD, Katz PP, Yelin EH, . Risk factors for hospitalization among adults with asthma: the influence of sociodemographic factors and asthma severity. Respir Res 2001; 2:53–60
   PubMed Web of Science ®Google Scholar
• Adams RJ, Smith BJ, Ruffin RE. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax 2000; 55:566–73
   PubMed Web of Science ®Google Scholar
• Griswold SK, Nordstrom CR, Clark S, . Asthma exacerbations in North American adults: who are the “frequent fliers” in the emergency department? Chest 2005; 127:1579–86
   Google Scholar
• National Center for Health Statistics. Asthma. Available from http://www.cdc.gov/nchs/fastats/asthma.htm [Last accessed 1 Nov 2007]
   Google Scholar
• Centers for Disease Control and Prevention: U.S. 12 Dec 2006Department of Health and Human Services: vital and health statistics ‘The state of childhood asthma, United States, 1980–2005’ Advanced Data No. 381
   Google Scholar
• Haas JS, Cleary PD, Guadagnoli E, . The impact of socioeconomic status on the intensity of ambulatory treatment and health outcomes after hospital discharge for adults with asthma. J Gen Intern Med 1994; 9:121–6
   PubMed Web of Science ®Google Scholar
• Hartert TV, Windom HH, Peebles RS Jr, . Inadequate outpatient medical therapy for patients with asthma admitted to two urban hospitals. Am J Med 1996; 100:386–94
   PubMed Web of Science ®Google Scholar
• Nelson HS, Weiss ST, Bleecker ER, . The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129:15–26
   PubMed Web of Science ®Google Scholar
• Nathan RA, Rooklin A, Schoaf L, . Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized double-blind, placebo-controlled, 12 week study. Clin Ther 2006; 28:73–85
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225–44
   PubMed Web of Science ®Google Scholar
• Bateman E, Boushey H, Bousquet J, . Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control Study. Am J Respir Crit Care Med 2004; 170:836–44
   PubMed Web of Science ®Google Scholar
• Wallin A, Sue-Chu M, Bjermer L, . Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma. J Allergy Clin Immunol 2003; 112:72–8
   PubMed Web of Science ®Google Scholar
• Lemanske RF, Sorkness CA, Mauger EA, . Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol. JAMA 2001; 285:2594–603
   PubMed Web of Science ®Google Scholar
• Shrewsbury S, Pyke S, Britton M, . Meta-analysis of increased doses of inhaled steroids or addition of salmeterol in symptomatic asthma (MIASMA). Br Med J 2000; 320:1368–73
   PubMed Web of Science ®Google Scholar
• Li X, Ward C, Thien F, . An inflammatory effect of salmeterol, a long-acting beta2-agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am J Respir Crit Care Med 1999; 160:1493–9
   PubMed Web of Science ®Google Scholar
• Greening AP, Ind P, Northfield M, . Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344:219–24
   PubMed Web of Science ®Google Scholar
• Ind PW, Dal Negro R, Colman NC, . Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma. Respir Med 2003; 97:555–62
   PubMed Web of Science ®Google Scholar
• Kavuru M, Melamed J, Gross G, . Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2000; 1506:1108–16
   Google Scholar
• Shapiro G, Lumry W, Wolfe J, . Combined salmeterol 50 mcg and fluticasone propionate 250 mcg in the diskus device for the treatment of asthma. Am J Respir Crit Care Med 2000; 161:527–34
   PubMed Web of Science ®Google Scholar
• O'Byrne PM, Bisgaard H, Godard PP, . Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005; 171:129–36
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Lofdahl CG, Postma DS, . Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337:1405–11
   PubMed Web of Science ®Google Scholar
• National Institute of Health. Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health National Heart, Lung and Blood Institute. July 2007 NHLBI/WHO workshop report, Publication Number 08–4051
   Google Scholar
• Nelson H, Wolfe J, Gross G, . Efficacy and safety of fluticasone propionate 44 μg/salmeterol 21 μg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment. Ann Allergy Asthma Immunol 2003; 91:263–69
   PubMed Web of Science ®Google Scholar
• Weiler JM, Nathan RA, Rupp N, . Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma. Ann Allergy Asthma Immunol 2005; 94:65–72
   PubMed Web of Science ®Google Scholar
• Nathan RA, Kalberg C, Jones S, . Effects of fluticasone propionate/salmeterol combination product on activity Induced bronchospasm in patients with persistent asthma. J Allergy Clin Immunol 2002; 109:S236
   Web of Science ®Google Scholar
• Szefler SJ, Martin RJ, King TS, . Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002; 109:410–8
   PubMed Web of Science ®Google Scholar
• Masoli M, Weatherall M, Holt S, . Systemic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child 2004; 89:902–7
   PubMed Web of Science ®Google Scholar
• Rodrigo G, Rodrigo C. A new index for early prediction of hospitalization in patients with acute asthma. Am J Emergency Med 1997; 15:8–13
   PubMed Web of Science ®Google Scholar
• Tattersfield AE, Postma DS, Barnes PJ, . Exacerbations of asthma: a descriptive study of 425 severe exacerbations. Am J Respir Crit Care Med 1999; 160:594–9
   PubMed Web of Science ®Google Scholar
• Reddel HK, Taylor DR. Report from ERS/ATS task force on asthma control and exacerbationsPresented at the Annual Meeting of the American Thoracic SocietySan Francisco, CA, USA21 May2007
   Google Scholar